These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16753500)

  • 21. Decompensated heart failure and cachexia: Is it time to legalize anabolics?
    Filippatos G; Rauchhaus M; Anker SD
    Int J Cardiol; 2006 Jul; 111(1):185-6. PubMed ID: 16828897
    [No Abstract]   [Full Text] [Related]  

  • 22. Which children with idiopathic short stature should receive growth hormone therapy?
    Czernichow P
    Nat Clin Pract Endocrinol Metab; 2008 Mar; 4(3):118-9. PubMed ID: 18040291
    [No Abstract]   [Full Text] [Related]  

  • 23. Digoxin therapy for heart failure: an update.
    Morris SA; Hatcher HF; Reddy DK
    Am Fam Physician; 2006 Aug; 74(4):613-8. PubMed ID: 16939183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A brief review of the addition of gonadotropin-releasing hormone agonists (GnRH-Ag) to growth hormone (GH) treatment of children with idiopathic growth hormone deficiency: Previously published studies from America.
    Reiter EO
    Mol Cell Endocrinol; 2006 Jul; 254-255():221-5. PubMed ID: 16787696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Underutilization of evidence-based therapies in heart failure: the pharmacist's role.
    Rodgers JE; Stough WG
    Pharmacotherapy; 2007 Apr; 27(4 Pt 2):18S-28S. PubMed ID: 17381371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure.
    von Haehling S; Doehner W; Anker SD
    Cardiovasc Res; 2007 Jan; 73(2):298-309. PubMed ID: 17034772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hormone therapy in cardiac insufficiency].
    Popovici D
    Stud Cercet Endocrinol; 1966; 17(5):497-500. PubMed ID: 5973970
    [No Abstract]   [Full Text] [Related]  

  • 29. TNF-alpha levels in children with growth hormone deficiency and the effect of long-term growth hormone replacement therapy.
    Andiran N; Yordam N
    Growth Horm IGF Res; 2007 Apr; 17(2):149-53. PubMed ID: 17314057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment.
    Gelato M; McNurlan M; Freedland E
    Clin Ther; 2007 Nov; 29(11):2269-88. PubMed ID: 18158071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone therapy does not induce cancer.
    Sheppard MC
    Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):532-3. PubMed ID: 17024147
    [No Abstract]   [Full Text] [Related]  

  • 32. Current guidelines for treatment of heart failure: 2006 update.
    Uddin N; Patterson JH
    Pharmacotherapy; 2007 Apr; 27(4 Pt 2):12S-17S. PubMed ID: 17381370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone treatments for adult disorders.
    Manag Care Interface; 2005; Suppl():6-7. PubMed ID: 16268196
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapy of heart failure in the elderly].
    Zobel C; Schwinger RH
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():47-50. PubMed ID: 16802519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone and the transition from puberty into adulthood.
    Attanasio AF; Shalet SM
    Endocrinol Metab Clin North Am; 2007 Mar; 36(1):187-201. PubMed ID: 17336740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasopressin and vasopressin receptor antagonists in heart failure.
    Oghlakian G; Klapholz M
    Cardiol Rev; 2009; 17(1):10-5. PubMed ID: 19092365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Heart failure].
    Aguilera RM; Colet JC; Castillo JJ; Jiménez JF
    Rev Esp Cardiol; 2008 Feb; 61 Suppl 1():48-57. PubMed ID: 18341935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of gene expression in rats with heart failure treated with the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) and the combination of DITPA and captopril.
    Maitra N; Adamson C; Greer K; Klewer S; Hoying J; Bahl JJ; Goldman S; Morkin E
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):526-34. PubMed ID: 18030062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-blocker therapy for patients with ventricular heart failure and reduced systolic function.
    Giles TD
    Postgrad Med; 2003 Dec; 114(6 Suppl Role):18-29. PubMed ID: 19667666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of intrauterine growth restriction with maternal growth hormone supplementation in sheep.
    de Boo HA; Eremia SC; Bloomfield FH; Oliver MH; Harding JE
    Am J Obstet Gynecol; 2008 Nov; 199(5):559.e1-9. PubMed ID: 18599015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.